Amna Ali, Ph.D.
Affiliations: | 2014 | Mercer University, Macon, GA, United States |
Area:
Cell BiologyGoogle:
"Amna Ali"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Diane F. Matesic | grad student | 2014 | Mercer University | |
| (Preclinical studies of chaetoglobosin K and 4-phenyl-3-butenoic acid in tumorigenic cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ali A, Burns TJ, Lucrezi JD, et al. (2015) Amidation inhibitors 4-phenyl-3-butenoic acid and 5-(acetylamino)-4-oxo-6-phenyl-2-hexenoic acid methyl ester are novel HDAC inhibitors with anti-tumorigenic properties. Investigational New Drugs. 33: 827-34 |
| Burns TJ, Ali A, Matesic DF. (2015) Comparative effects of 4-phenyl-3-butenoic acid and vorinostat on cell growth and signaling. Anticancer Research. 35: 775-84 |
| Ali A, Caggia S, Matesic DF, et al. (2015) Abstract 2669: Chaetoglobosin K, an Akt pathway inhibitor, prevents proliferation and migration of prostate carcinoma cells Cancer Research. 75: 2669-2669 |
| Ali A, Matesic DF. (2014) Abstract 4523: Chaetoglobosin K, a dual Akt and JNK inhibitor, modulates Akt phosphorylation in an mTORC2 independent manner Cancer Research. 74: 4523-4523 |
| Matesic DF, Ali A, Sidorova TS, et al. (2013) A Cell-Cell Communication Marker for Identifying Targeted Tumor Therapies. Current Bioactive Compounds. 9: 255-262 |
| Ali A, Sidorova TS, Matesic DF. (2013) Dual modulation of JNK and Akt signaling pathways by chaetoglobosin K in human lung carcinoma and ras-transformed epithelial cells. Investigational New Drugs. 31: 525-34 |
| Ali A, Matesic DF. (2012) Abstract 1810: Mechanistic studies of the dual Akt and JNK inhibitor Chaetoglobosin K: Effect on downstream pathways and AP-1 proteins in tumorigenic cells Cancer Research. 72: 1810-1810 |